Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (131-140 of 292) with videos related to

Pageof 30
Sort By:
Circulation|June 30, 2010
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humansAndrew S Flett, Martin P Hayward, Michael T Ashworth, et al.
Journal of the American College of Cardiology|July 9, 2011
Prevalence of J-point elevation in sudden arrhythmic death syndrome familiesLaurence M Nunn, Justine Bhar-Amato, Martin D Lowe, et al.
Journal of the American College of Cardiology|October 24, 2002
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteriaM Shoaib Hamid, Mark Norman, Asifa Quraishi, et al.
Circulation|May 25, 2011
Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteriaGiovanni Quarta, Alison Muir, Antonios Pantazis, et al.
Journal of the American College of Cardiology|July 21, 2004
Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophyRajesh Thaman, Juan R Gimeno, Sebastian Reith, et al.
Molecular Genetics and Metabolism|January 27, 2007
Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathyAnita M Arola, Ximena Sanchez, Ross T Murphy, et al.
Molecular Genetics and Metabolism|May 23, 2018
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of expertsMarco Spada, Ralf Baron, Perry M Elliott, et al.
European Journal of Heart Failure|November 18, 2017
Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathyRichard Collis, Oliver Watkinson, Constantinos O'Mahony, et al.
The American Journal of Cardiology|October 9, 2012
Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry diseaseCaroline J Coats, Valentina Parisi, Monica Ramos, et al.
Journal of the American College of Cardiology|February 2, 2002
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathyNiall G Mahon, Brendan P Madden, Alida L P Caforio, et al.
Pageof 30

Showing results (131-140 of 292) with videos related to

Sort By:
Pageof 30
Circulation|June 30, 2010
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humansAndrew S Flett, Martin P Hayward, Michael T Ashworth, et al.
Journal of the American College of Cardiology|July 9, 2011
Prevalence of J-point elevation in sudden arrhythmic death syndrome familiesLaurence M Nunn, Justine Bhar-Amato, Martin D Lowe, et al.
Journal of the American College of Cardiology|October 24, 2002
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteriaM Shoaib Hamid, Mark Norman, Asifa Quraishi, et al.
Circulation|May 25, 2011
Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteriaGiovanni Quarta, Alison Muir, Antonios Pantazis, et al.
Journal of the American College of Cardiology|July 21, 2004
Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophyRajesh Thaman, Juan R Gimeno, Sebastian Reith, et al.
Molecular Genetics and Metabolism|January 27, 2007
Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathyAnita M Arola, Ximena Sanchez, Ross T Murphy, et al.
Molecular Genetics and Metabolism|May 23, 2018
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of expertsMarco Spada, Ralf Baron, Perry M Elliott, et al.
European Journal of Heart Failure|November 18, 2017
Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathyRichard Collis, Oliver Watkinson, Constantinos O'Mahony, et al.
The American Journal of Cardiology|October 9, 2012
Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry diseaseCaroline J Coats, Valentina Parisi, Monica Ramos, et al.
Journal of the American College of Cardiology|February 2, 2002
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathyNiall G Mahon, Brendan P Madden, Alida L P Caforio, et al.
Pageof 30